{"id":1316,"date":"2013-04-26T13:44:23","date_gmt":"2013-04-26T17:44:23","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/?page_id=1316"},"modified":"2013-04-26T13:47:50","modified_gmt":"2013-04-26T17:47:50","slug":"study-on-inhalable-parkinsons-medication","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/center\/study-on-inhalable-parkinsons-medication\/","title":{"rendered":"Study on Inhalable Parkinson&#8217;s Disease Medication"},"content":{"rendered":"<p>Researchers at Boston University Medical Campus are studying an investigational drug called CVT-301. The active ingredient in CVT-301 is levodopa, and is taken by using an inhaler, much like how asthma medication is inhaled. It is hoped that this will result in a more rapid relief of some Parkinson\u2019s disease symptoms.<\/p>\n<p>If you are taking Sinemet (Levodopa\/Carbidopa) you may be eligible to participate in this study.<\/p>\n<p>If you are interested in this study, please contact the researchers at Boston University Medical Center at 617-638-7745 or 617-638-7737 for more information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers at Boston University Medical Campus are studying an investigational drug called CVT-301. The active ingredient in CVT-301 is levodopa, and is taken by using an inhaler, much like how asthma medication is inhaled. It is hoped that this will result in a more rapid relief of some Parkinson\u2019s disease symptoms. If you are taking [&hellip;]<\/p>\n","protected":false},"author":4405,"featured_media":0,"parent":25,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/pages\/1316"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/users\/4405"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/comments?post=1316"}],"version-history":[{"count":4,"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/pages\/1316\/revisions"}],"predecessor-version":[{"id":1321,"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/pages\/1316\/revisions\/1321"}],"up":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/pages\/25"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/parkinsonsdisease\/wp-json\/wp\/v2\/media?parent=1316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}